Today: 17 April 2026
Browse Category

Mergers & Acquisitions 28 November 2025 - 1 December 2025

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Abbott Laboratories has agreed to acquire Exact Sciences for $105 per share in cash, valuing the deal at up to $23 billion including debt. Exact Sciences stock traded at $101.27 mid-day December 1, near its all-time high after a 56% surge in November. The transaction is expected to close in Q2 2026, pending approvals. The offer represents a 22% premium to Exact’s pre-deal price.
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio shares jumped as much as 170% intraday on December 1 after announcing the sale of its Phase 2 drug ADX-097 to Akebia Therapeutics for $12 million upfront and up to $592 million in milestones. Trading volume soared into the hundreds of millions. The company will now focus on its lead autoimmune drug, bempikibart, for alopecia areata.
ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

ServiceNow shares traded near $820 Monday, about 33% below January’s 52-week high and down 24% year-to-date, while the Nasdaq rose 20%. Third-quarter results beat expectations, with revenue up 22% to $3.41 billion and adjusted EPS at $4.82. The board has proposed a five-for-one stock split, with a shareholder vote set for December 5. Market cap stands at roughly $170 billion.
Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Zeekr Group (NYSE: ZK) last traded at about $26.70 per ADS, with a market cap near $6.8 billion, as Geely’s $26.87 per ADS take-private offer dominates trading. November deliveries hit 63,902 vehicles, up 7.1% year-over-year. The company launched sales in Germany on December 1, 2025, while Q3 revenue reached $4.43 billion with a gross margin of 19.2%. Zeekr remains loss-making and financially strained.
American Water Stock (AWK) in December 2025: Merger, Rate Hikes and Dividend Growth – What Investors Need to Know

American Water Stock (AWK) in December 2025: Merger, Rate Hikes and Dividend Growth – What Investors Need to Know

American Water Works shares traded near $130 on December 1, 2025, with a market cap around $25–26 billion. Q3 2025 earnings rose to $1.94 per share, beating estimates, and revenue climbed nearly 10% year-over-year to $1.45 billion. Management reaffirmed 2025 EPS guidance of $5.70–$5.75 and issued 2026 guidance of $6.02–$6.12 per share. The annual dividend stands at $3.31, yielding about 2.5%.
SolGold Stock Soars After Rejecting Jiangxi Copper’s $1 Billion Bid – What’s Next for SOLG / SLGGF?

SolGold Stock Soars After Rejecting Jiangxi Copper’s $1 Billion Bid – What’s Next for SOLG / SLGGF?

SolGold entered a formal takeover offer period after rejecting two non-binding bids from Jiangxi Copper at 26p per share in late November. The company’s share price surged following the approaches. SolGold delisted from Toronto in June and reorganized its assets, with new leadership aiming to accelerate Cascabel project development in Ecuador. The UK Takeover Panel set a 26 December 2025 deadline.
Spectris Share Price on 1 December 2025: KKR £41.75 Takeover Nears the Finish Line as New Voting and Stake Disclosures Land

Spectris Share Price on 1 December 2025: KKR £41.75 Takeover Nears the Finish Line as New Voting and Stake Disclosures Land

Spectris shares traded just below KKR’s £41.75-per-share offer ahead of expected delisting from the London Stock Exchange this week. Regulatory filings show Barclays holding roughly equal long and short positions of about 5% each, with trades clustered near £41.33. The company reported 99.4 million voting rights as of November 30. The deal spread remains just over 1%.
Anglo American (AAL) Stock Outlook 2025: Teck Merger, BHP Exit and Copper Boom Reshape the Investment Case

Anglo American (AAL) Stock Outlook 2025: Teck Merger, BHP Exit and Copper Boom Reshape the Investment Case

Anglo American shares closed at 2,851p in London ahead of December 1, up 15% over the year, with a market cap near £31 billion. BHP ended its takeover pursuit in late November, clearing the way for Anglo’s planned merger with Teck Resources. The deal would see Teck shareholders receive 1.3301 Anglo shares each and Anglo pay a US$4.5 billion special dividend. Analyst price targets hover just above current levels.
Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Pfizer closed at $25.74 on November 28, with a market cap near $146 billion, down about 50% from its 2021–22 COVID peak. Q3 2025 revenue fell 6–7% to $16.7 billion as COVID sales declined, but adjusted EPS beat at $0.87. The company raised 2025 EPS guidance to $3.00–$3.15 and reaffirmed revenue targets. On September 30, Pfizer agreed to cut Medicaid drug prices in exchange for U.S. export tariff relief.
Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group closed at $71.62 on Friday, up 0.17%, with volume surging 149% after completing its $13 billion all-stock merger with Interpublic Group. The deal makes Omnicom the world’s largest advertising holding company by revenue. Shares now trade near the bottom of their 52-week range, about 32% below the high. Omnicom is down 17% in 2025 despite a double-digit dividend hike and major balance-sheet moves.
Hanesbrands (HBI) Stock Outlook Before the December 1, 2025 Open: Russell Index Exit, Gildan Merger and Heavy Trading in Focus

Hanesbrands (HBI) Stock Outlook Before the December 1, 2025 Open: Russell Index Exit, Gildan Merger and Heavy Trading in Focus

Hanesbrands shares fell 1.8% to $6.47 Friday after being removed from multiple Russell indexes, triggering a surge in trading volume to 112 million shares—eight times the average. The stock closed down for a second day even as major indexes rose, with after-hours trading showing modest gains amid dip-buying and merger arbitrage activity.
Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom closed its $13.25 billion all-stock merger with Interpublic on November 26, following European Commission approval. The combined company, trading as OMC, saw share volume surge to 9.2 million Friday, while the stock closed at $71.62, still 31% below its 52-week high. John Wren remains CEO; former IPG chief Philippe Krakowsky joins as Co-President.
Hanesbrands (HBI) Stock on November 30, 2025: Index Removal, Gildan Merger and Heavy Trading – All the Latest News

Hanesbrands (HBI) Stock on November 30, 2025: Index Removal, Gildan Merger and Heavy Trading – All the Latest News

Hanesbrands was removed from the Russell 3000 and Russell 2000 Growth indexes on November 28, triggering heavy trading volume of 112 million shares and a 1.8% stock drop to $6.47. The company faces a pending $4.4 billion takeover by Gildan Activewear, with shareholders set to receive 0.102 Gildan shares and $0.80 in cash per HBI share.
Qualcomm (QCOM) Stock on November 30, 2025: AI Data Centers, Alphawave Deal and Arduino Acquisition Reframe the Story

Qualcomm (QCOM) Stock on November 30, 2025: AI Data Centers, Alphawave Deal and Arduino Acquisition Reframe the Story

Qualcomm closed Friday, Nov. 28, 2025, just under $168 per share, up about 1.8% in a light, post-holiday session, valuing the company near $180 billion. Shares are up 6% year-to-date, trailing the Nasdaq’s 19% gain, and remain over 20% below last year’s highs. The quarterly dividend stands at $0.89 per share, yielding about 2%. Fiscal Q4 revenue reported at $11.27 billion, up 10% year over year.
Palo Alto Networks (PANW) Stock on November 30, 2025: Chronosphere Deal, Quantum-Safe Push and CyberArk Merger Drive a Volatile Repricing

Palo Alto Networks (PANW) Stock on November 30, 2025: Chronosphere Deal, Quantum-Safe Push and CyberArk Merger Drive a Volatile Repricing

Palo Alto Networks closed at $190.13 on November 28, 2025, up 2.6% for the day but still 15–17% below its 52-week high. The company reported better-than-expected Q1 FY 2026 earnings, announced a $3.35 billion deal to acquire Chronosphere, and secured CyberArk shareholder approval for its purchase. Market cap stands near $133 billion, with a P/E ratio around 120x.
Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group closed its $13.25 billion all-stock acquisition of Interpublic Group on November 26, forming the world’s largest advertising holding company by revenue. Shares finished November 28 at $71.62, about 32% below their 52-week high. The company also completed a major exchange offer for IPG’s $2.95 billion in senior notes and announced a double-digit dividend increase. Trading remains volatile as investors assess the merger’s impact.
Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

Constellation Energy closed Friday at $364.36, up 1.47%, with a market cap near $114 billion and a P/E of about 42. The company secured a $1 billion U.S. loan to restart a nuclear reactor at Three Mile Island and is moving to finalize its $26.6 billion Calpine acquisition. Leadership changes were announced ahead of the merger. Q3 earnings missed estimates, but full-year guidance was narrowed to $9.05–$9.45 EPS.
Hanesbrands (HBI) Stock on November 29, 2025: Gildan Merger Vote, Q3 Earnings, and Heavy Trading Pressure

Hanesbrands (HBI) Stock on November 29, 2025: Gildan Merger Vote, Q3 Earnings, and Heavy Trading Pressure

Hanesbrands shares fell 1.82% to $6.47 on November 28, 2025, underperforming major indexes amid trading volume of 112.1 million shares, far above average. On November 25, shareholders approved the company’s merger with Gildan Activewear, with 243.9 million votes in favor. The Hart–Scott–Rodino antitrust waiting period expired November 20. The deal awaits further regulatory approvals and closing conditions.
BP Share Price Today, 28 November 2025: Buybacks, Castrol Deal Talks and Olympic Pipeline News Shape the Outlook

BP Share Price Today, 28 November 2025: Buybacks, Castrol Deal Talks and Olympic Pipeline News Shape the Outlook

BP shares closed up 1.6% at 454.2p in London on Friday, near the top of the day’s range, as investors reacted to steady oil prices, a new buyback, and Castrol sale talks. About 17.7 million shares traded. BP’s market cap stands at roughly $93 billion, with a dividend yield around 5.3%. BP ADRs in New York also gained, trading near recent highs.
El Jannah Sold to US Private Equity Giant General Atlantic in Near-$1 Billion Deal, with Plans to Quadruple Stores and Go Global

El Jannah Sold to US Private Equity Giant General Atlantic in Near-$1 Billion Deal, with Plans to Quadruple Stores and Go Global

General Atlantic has acquired a major stake in El Jannah, valuing the Australian charcoal chicken chain at up to A$1 billion, according to multiple reports. The Estephan family retains a minority shareholding, with CEO Brett Houldin staying on. El Jannah plans to expand from 50 to nearly 200 outlets, including its first overseas locations in the Middle East.
28 November 2025
1 9 10 11 12 13 20

Stock Market Today

  • Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models
    April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast, a discounted cash flow (DCF) model values shares at $47.64, signaling overvaluation based on cash flow projections. This valuation split highlights uncertain assumptions about Symbotic's ability to translate its backlog into sustainable cash earnings, with risks including customer concentration and contract delays.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:47 AM EDT Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast,
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop